Nrf2 activation orchestrates a complex transcriptional program that mitigates COPD pathogenesis primarily by regulating key downstream effectors involved in antioxidant defense, inflammation resolution, and cellular homeostasis, as partially illustrated in Table 1 and further detailed in the following sections regarding downstream targets. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.